文献速递细菌感染、耐药与抗菌药物医院感染防控

全基因组测序与微生物组分析联合揭示侵袭性多重耐药表皮葡萄球菌的克隆性出现

Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.
PubMed 文献 · Clin Infect Dis · 2018-01-01

对2013至2016年MD安德森癌症中心收集的176株表皮葡萄球菌血流分离株进行全基因组测序,发现39株(22%)对利奈唑胺耐药,其中31株由同一多重耐药克隆引起并在白血病患者间传播,该克隆携带位于49 kb质粒pMB151a上的cfr基因。白血病患者连续粪便样本分析显示,利奈唑胺使用后肠道菌群中葡萄球菌逐渐占优势且cfr丰度增加。作者认为利奈唑胺使用加上多重耐药克隆传播驱动了侵袭性利奈唑胺耐药表皮葡萄球菌的扩增。

要点

  • 176株血流分离株中39株(22%)对利奈唑胺耐药。
  • 39株利奈唑胺耐药株中31株由同一多重耐药克隆引起,在白血病患者间传播。
  • 该克隆携带cfr的49 kb质粒pMB151a,其cfr周围6 kb与来自中国畜禽相关葡萄球菌的cfr质粒近100%相同。

核心结论

  • 利奈唑胺使用加上多重耐药克隆的传播驱动了侵袭性利奈唑胺耐药表皮葡萄球菌的扩增。
  • 作者认为抗菌药物管理联合感染控制措施可能有助于控制多重耐药致病共生菌的传播。

研究设计与样本

  • 对2013至2016年在美国德克萨斯州休斯顿MD安德森癌症中心收集的176株表皮葡萄球菌血流分离株进行全基因组测序。
  • 通过互补的系统发育基因组学方法评估分子关系。
  • 通过逆转录定量聚合酶链反应测定粪便样本中利奈唑胺耐药决定因子cfr的丰度。

主要发现

  • 176株菌株中39株对利奈唑胺耐药(22%)。
  • 39株利奈唑胺耐药表皮葡萄球菌感染中31株由同一多重耐药克隆引起,该克隆在白血病患者间传播并携带位于49 kb质粒pMB151a上的cfr。
  • pMB151a上cfr基因周围6 kb与从中国畜禽相关葡萄球菌中分离的含cfr质粒近100%相同。
  • 白血病患者连续粪便样本分析显示,利奈唑胺使用后肠道菌群中葡萄球菌逐渐占优势且cfr丰度增加。

临床怎么用

  • 作者认为抗菌药物管理联合感染控制措施可能有助于控制多重耐药致病共生菌的传播。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pathobionts, bacteria that are typically human commensals but can cause disease, contribute significantly to antimicrobial resistance. Staphylococcus epidermidis is a prototypical pathobiont as it is a ubiquitous human commensal but also a leading cause of healthcare-associated bacteremia. We sought to determine the etiology of a recent increase in invasive S. epidermidis isolates resistant to linezolid. METHODS: Whole-genome sequencing (WGS) was performed on 176 S. epidermidis bloodstream isolates collected at the MD Anderson Cancer Center in Houston, Texas, between 2013 and 2016. Molecular relationships were assessed via complementary phylogenomic approaches. Abundance of the linezolid resistance determinant cfr was determined in stool samples via reverse-transcription quantitative polymerase chain reaction. RESULTS: Thirty-nine of the 176 strains were linezolid resistant (22%). Thirty-one of the 39 linezolid-resistant S. epidermidis infections were caused by a particular clone resistant to multiple antimicrobials that spread among leukemia patients and carried cfr on a 49-kb plasmid (herein called pMB151a). The 6 kb of pMB151a surrounding the cfr gene was nearly 100% identical to a cfr-containing plasmid isolated from livestock-associated staphylococci in China. Analysis of serial stool samples from leukemia patients revealed progressive staphylococcal domination of the intestinal microflora and an increase in cfr abundance following linezolid use. CONCLUSIONS: The combination of linezolid use plus transmission of a multidrug-resistant clone drove expansion of invasive, linezolid-resistant S. epidermidis. Our results lend support to the notion that a combination of antibiotic stewardship plus infection control measures may help to control the spread of a multidrug-resistant pathobiont.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Li X, Arias CA, Aitken SL, et al. Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses. Clin Infect Dis. 2018. PMID: 29546356. doi:10.1093/cid/ciy089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。